{'fraction_non_alphanumeric': 0.02785923753665689, 'fraction_numerical': 0.005865102639296188, 'mean_word_length': 5.696078431372549, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Human brain and serum advanced glycation end products are highly correlated: Preliminary results of their role in Alzheimer’s disease and type 2 diabetes

Serum levels of advanced glycation end products (AGEs), a large group of pro‐oxidant and pro‐inflammatory compounds, particularly carboxymethyl lysine (CML) and methylglyoxal (MG), are generated endogenously and by dietary consumption2. Accumulating evidence suggests that modifying dietary AGEs consumption might affect the accumulation of AD pathology and dementia especially those with type 2 diabetes (T2D). However, there is a paucity of human data about the relationship of serum and brain levels of AGEs in older adults.